Aortic Valve Market Research, Size, Key Market Players, SWOT, Revenue Growth Analysis Till 2027
Aortic Valve Market held a value of USD 6,454.91 Million in 2018, at a CAGR of 11.1% during the assessment period.
The growth
of the global aortic valve market is boosted by various factors such as the
rising geriatric population, surge in prevalence of cardiac disorders, in
conjunction with the introduction of innovative products in the market.
According to the Heart Valve Voice, approximately 1.5 million people over the
age of 65 years are currently affected by heart valve disease in the UK, and
the number is expected to increase up to 19 million by 2050. Moreover,
increasing product approvals are likely to provide favorable conditions for the
growth of the market. For instance, in June 2017, the US FDA granted market
clearance for aortic and mitral valve-in-valve procedures using the Edwards
Lifesciences Sapien 3 transcatheter heart valve (THV).
An aortic
valve is surgically implanted in the heart to replace a valve that has damaged
due to heart valve diseases such as aortic stenosis,
regurgitation, and atresia. The replacement of damaged valves with prosthetic
heart valves reduces the morbidity and mortality associated with aortic valve
disorders.
However,
product recalls due to safety reasons and changing regulatory landscapes are
likely to hamper the growth of the market during the forecast period.
Several
market players currently dominate the global aortic valve market. The key
players are engaged in product launches and strategic collaborations to
strengthen their market positions.
Regional
Analysis
The Aortic
Valve market research has been divided, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The Americas held the
maximum share in the base year 2018, owing to the presence of established key
players in countries such as the US and Canada. The aortic valve market in the
Americas has further been branched into North America and Latin America, with
the North American market is further divided into the US and Canada. The European
aortic valve market has been categorized as Western Europe and Eastern Europe.
The Western European market has been classified as Germany, France, the UK,
Italy, Spain, and the rest of Western Europe. The aortic valve market in
Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific. The aortic valve market in this region
is anticipated to be the fastest growing during the assessment period due to
the booming geriatric population, rising prevalence of cardiovascular diseases,
and favorable government initiatives for disease treatment. The aortic valve
market in the Middle East & Africa has been divided into the Middle East
and Africa.
Aortic
Valve Market Segmentation
The Global
Aortic Valve Market has been segmented based on Type of Valve, Suture, Surgery,
and End User.
The market,
based on valve type, has been divided into mechanical and biological. The
mechanical valve segment is likely to be the largest due to the high adoption
of mechanical in aortic
valve replacement procedures. The biological
valves segment is predicted to be the fastest-growing due to the increasing
awareness about the advantages of biological valves in replacement procedures.
Magna Ease (Edwards Lifesciences Corporation), Hancock II (Medtronic), Trifecta
(Abbott) are some of the well-known biological valves’ brands currently present
in the market.
The Global
Aortic Valve Market has been segmented, based on the surgery type, into
minimally invasive surgery and open surgery. The minimally invasive surgery
segment is further divided into transfemoral, transaortic implantation,
transapical, and trans-subclavian. It is expected to hold majority share of the
market owing to shorter hospital stay, less pain, and faster recovery as
compared to open-heart surgery.
The end
users of the market are hospitals, ambulatory surgery centers. The hospital
segment is likely to hold the maximum share during the forecast period.
Key
Players
Some of the
key players in the Global Aortic Valve Market are Boston Scientific Corporation (US),
Medtronic(US), Abbott Laboratories (US), LivaNova PLC (UK), Edwards
Lifesciences Corporation (US), CryoLife (US), Biotronik (Germany), Colibri
Heart Valve (US), JenaValve (US), and TTK HealthCare (India), among
others.
Access
Report Details @ https://www.marketresearchfuture.com/reports/aortic-valve-market-8632
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street, 5Th Floor,
New York,
New York 10013
United
States of America
+1 628 258
0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment